Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Reviva Pharmaceuticals Hldg Inc (RVPH)

Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 66,882
  • Shares Outstanding, K 33,441
  • Annual Sales, $ 0 K
  • Annual Income, $ -39,260 K
  • EBIT $ -35 M
  • EBITDA $ -35 M
  • 60-Month Beta -0.12
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 112.72% ( -1.55%)
  • Historical Volatility 214.05%
  • IV Percentile 29%
  • IV Rank 9.98%
  • IV High 944.78% on 10/03/24
  • IV Low 20.50% on 07/12/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 5,266
  • Volume Avg (30-Day) 6,394
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 72,012
  • Open Int (30-Day) 71,728

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.22
  • Number of Estimates 3
  • High Estimate -0.19
  • Low Estimate -0.26
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +37.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.25 +55.20%
on 12/23/24
2.17 -10.60%
on 01/07/25
+0.60 (+44.78%)
since 12/20/24
3-Month
0.88 +119.95%
on 11/11/24
4.28 -54.67%
on 12/09/24
+0.50 (+34.72%)
since 10/22/24
52-Week
0.60 +223.33%
on 08/16/24
4.83 -59.83%
on 02/13/24
-1.96 (-50.26%)
since 01/22/24

Most Recent Stories

More News
Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

RVPH : 1.94 (-3.00%)
Reviva Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants

Reviva Pharmaceuticals plans to offer common stock and warrants to fund R&D and corporate needs, pending market conditions.Quiver AI SummaryReviva Pharmaceuticals Holdings, Inc. has announced a proposed...

RVPH : 1.94 (-3.00%)
Reviva Announces Pricing of $18.0 Million Public Offering of Common Stock and Warrants

RVPH : 1.94 (-3.00%)
Reviva Announces Proposed Public Offering

RVPH : 1.94 (-3.00%)
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia

RVPH : 1.94 (-3.00%)
Reviva Pharmaceuticals Reports Progress on Brilaroxazine Trials and Financial Results for Q3 2024

Reviva Pharmaceuticals reports 108 patients completed a trial for schizophrenia treatment, with topline data expected December 2024.Quiver AI SummaryReviva Pharmaceuticals Holdings, Inc. announced that...

RVPH : 1.94 (-3.00%)
Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

RVPH : 1.94 (-3.00%)
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

Earnings have largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.

ALDX : 5.03 (+2.86%)
STIM : 2.35 (+4.91%)
PGY : 9.12 (-1.62%)
QSI : 2.38 (-2.46%)
MNOV : 1.8100 (-1.63%)
AXSM : 102.27 (+6.33%)
VSAT : 10.77 (-8.81%)
ZS : 192.93 (+0.58%)
BTM : 1.7100 (unch)
RVPH : 1.94 (-3.00%)
SPY : 606.44 (+0.56%)
XBI : 91.21 (+0.77%)
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

RVPH : 1.94 (-3.00%)
Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024

RVPH : 1.94 (-3.00%)

Business Summary

Reviva Pharmaceuticals Inc. is a clinical stage pharmaceutical company. It engages in developing therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company's lead product candidate includes RP5063, for the treatment...

See More

Key Turning Points

3rd Resistance Point 2.27
2nd Resistance Point 2.15
1st Resistance Point 2.05
Last Price 1.94
1st Support Level 1.83
2nd Support Level 1.71
3rd Support Level 1.61

See More

52-Week High 4.83
Fibonacci 61.8% 3.21
Fibonacci 50% 2.72
Fibonacci 38.2% 2.22
Last Price 1.94
52-Week Low 0.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar